Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.88 USD | -0.44% | -2.04% | -33.40% |
May. 21 | Sector Update: Financial Stocks Higher Late Afternoon | MT |
May. 21 | Sector Update: Financial Stocks Edge Up Tuesday Afternoon | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company is not the most generous with respect to shareholders' compensation.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-33.34% | 7.5B | B- | ||
+5.33% | 101B | B | ||
+11.66% | 100B | B- | ||
-14.25% | 84.31B | B+ | ||
+19.42% | 74.31B | D+ | ||
+19.22% | 34.25B | B | ||
+18.22% | 30.7B | B | ||
-0.47% | 17.31B | C+ | ||
-12.95% | 14.31B | B | ||
+18.97% | 12.73B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GL Stock
- Ratings Globe Life Inc.